• lejuarezorozco

Recruitment is on-schedule!

The GIPS-IV trial has already enrolled 130 patients!

We expect to conclude enrolment by 2020.


First results will be expected by 2021.


© 2019 by ITC Team |  Terms of Use  |   Privacy Policy